跳至主要内容
临床试验/NCT05184894
NCT05184894已完成不适用

AKI in Care Transitions (ACT) Trial

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2022年1月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
50
试验地点
2
主要终点
Number of Subjects to Complete the ACT Program

研究概览

简要总结

This research is being done to develop materials and processes that will help facilitate education and kidney care coordination for AKI survivors.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants will be recruited from those identified by a developed electronic health record list of patients with stage III AKI (severe) during a hospitalization based on serum creatinine rise or urine output decline from Olmsted County.

排除标准

  • Dementia.
  • Non-English speaking.
  • Expected to be dismissed to a skilled nursing facility or hospice at discharge.
  • Expected to need dialysis at discharge.
  • Primary Care Transitions Program enrollment.
  • Transplant recipients within 100 days of transplant.
  • Can only have one time enrollment.

研究组 & 干预措施

Usual Care Group

No Intervention

Subjects diagnosed with Acute Kidney Injury (AKI) during their hospital stay will receive standard of care from their inpatient and outpatient care teams.

AKI in Care Transitions (ACT) Group

Experimental

Subjects diagnosed with Acute Kidney Injury (AKI) during their hospital stay will participate in the ACT program which provides standardized education and assists with coordination of follow up care after hospital stay.

干预措施: AKI in Care Transitions (ACT) program (Behavioral)

结局指标

主要结局

Number of Subjects to Complete the ACT Program

时间窗: 30 days after hospitalization

Total number of subjects to complete the full ACT program intervention

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Erin Barreto

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验

已完成
不适用
Therapy BRIDGE (Bringing Real-Time Instruction Via Developmental and Gestationally-appropriate Education/Coaching) Program: a Pilot StudyIntraventricular Hemorrhage
NCT06256939Children's Hospital Medical Center, Cincinnati15
已完成
不适用
Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced CancerStage IV MelanomaStage IV Non-Small Cell Lung CancerUnresectable Non-Small Cell Lung CarcinomaUnresectable Stage III Non-Small Cell Lung CancerSmall Cell Lung Cancer Extensive StageStage IV Merkel Cell CarcinomaStage IV Cutaneous Squamous Cell CarcinomaStage IV Basal Cell CarcinomaStage IV Breast CancerStage IV Colorectal CancerStage IV Gastric CancerStage IV Esophageal CancerStage IV Hepatocellular CancerStage IV Renal Cell CarcinomaStage IV Bladder CancerStage IV Head and Neck Squamous Cell CarcinomaStage IV Cervical CancerStage IV Endometrial CancerStage IV MesotheliomaImmunotherapyImmune Checkpoint InhibitorsAdvanced Lung Cancer
NCT04670445Massachusetts General Hospital199
已完成
不适用
Formative Research to Develop an Intervention Package to Promote Practice of Kangaroo Mother Care for Low Birth Weight and Preterm Infants in a Community (CKMC)Low-Birth-Weight
NCT02613624Society for Applied Studies28
已完成
不适用
Using The HOPES Program in Transition CareSerious Mental IllnessPsychosocial Rehabilitation
NCT02420340Dartmouth-Hitchcock Medical Center12
已完成
不适用
Pioneering Advances in Care and Education (PACE)Decision Support Systems, ClinicalProstate Cancer
NCT03397160University of California, San Francisco119